Abstract | BACKGROUND: METHODS: RESULTS: Fifty-two Wallstents were inserted in 36 patients, with 7, 13, and 16 having, respectively, Bismuth type I/II, III, and IV lesions. Insertion was successful in 35 of 36 (97%) patients. Complications occurred within the first 30 days after insertion in 5 patients (14%) but did not require biliary reintervention. Thirty-day mortality was 6% (2 deaths). There were 3 early (9%) and 8 late (23%) stent occlusions, bringing the total to 11 patients (31%) who required biliary reintervention after Wallstent insertion. Median Wallstent patency and patient survival were, respectively, 169 days (95% CI [154, 184]) and 147 days (95% CI [106, 188]), with no difference between patients with Bismuth I/II, III, IV type tumors. CONCLUSIONS: Wallstent insertion is safe and feasible, and achieves successful palliation without the need for further biliary reintervention in the majority (69%) of patients with nonresectable hilar cholangiocarcinoma.
|
Authors | John L S Cheng, Marco J Bruno, Jacques J Bergman, Erik A Rauws, Guido N Tytgat, Kees Huibregtse |
Journal | Gastrointestinal endoscopy
(Gastrointest Endosc)
Vol. 56
Issue 1
Pg. 33-9
(Jul 2002)
ISSN: 0016-5107 [Print] United States |
PMID | 12085032
(Publication Type: Evaluation Study, Journal Article)
|
Topics |
- Bile Duct Neoplasms
(complications, mortality)
- Bile Ducts, Intrahepatic
- Biliary Tract Diseases
(therapy)
- Cholangiocarcinoma
(complications, mortality)
- Cholestasis
(therapy)
- Endoscopy, Digestive System
- Female
- Humans
- Male
- Middle Aged
- Palliative Care
- Prosthesis Failure
- Retrospective Studies
- Stents
|